Maloberti Renaud Bertrand 4
4 · ENDRA Life Sciences Inc. · Filed Jan 14, 2021
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-01-12$1.05/sh−6,304$6,619→ 15,276 total - Sale
Common Stock
2021-01-13$1.10/sh−13,696$15,066→ 1,580 total
Footnotes (1)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan.